Skip to main content
Fig. 3 | Experimental Hematology & Oncology

Fig. 3

From: IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons ≥ 60 years with myelodysplastic syndromes

Fig. 3

Overall survival of MDS patients stratified according to different prognostic scoring systems. Kaplan–Meier representation of each scoring systems in our cohort. A IPSS-R risk categories, B IPSS-M risk categories. P-values are from the log-rank test. Abbreviations: IPSS-R: International Prognostic Scoring System-Revised; IPSS-M: International Prognostic Scoring System-Molecular; OS: overall survival; VL: very low; Inter: intermediate; VH: very high

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us